17-59893319-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000225577.9(RPS6KB1):c.135G>A(p.Glu45=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00138 in 1,607,990 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 11 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 12 hom. )
Consequence
RPS6KB1
ENST00000225577.9 synonymous
ENST00000225577.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.30
Genes affected
RPS6KB1 (HGNC:10436): (ribosomal protein S6 kinase B1) This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 17-59893319-G-A is Benign according to our data. Variant chr17-59893319-G-A is described in ClinVar as [Benign]. Clinvar id is 781310.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00756 (1152/152328) while in subpopulation AFR AF= 0.0262 (1088/41562). AF 95% confidence interval is 0.0249. There are 11 homozygotes in gnomad4. There are 532 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1152 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KB1 | NM_003161.4 | c.135G>A | p.Glu45= | synonymous_variant | 1/15 | ENST00000225577.9 | NP_003152.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KB1 | ENST00000225577.9 | c.135G>A | p.Glu45= | synonymous_variant | 1/15 | 1 | NM_003161.4 | ENSP00000225577 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00758 AC: 1153AN: 152210Hom.: 11 Cov.: 32
GnomAD3 genomes
AF:
AC:
1153
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00187 AC: 435AN: 232282Hom.: 6 AF XY: 0.00136 AC XY: 172AN XY: 126768
GnomAD3 exomes
AF:
AC:
435
AN:
232282
Hom.:
AF XY:
AC XY:
172
AN XY:
126768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000728 AC: 1059AN: 1455662Hom.: 12 Cov.: 31 AF XY: 0.000619 AC XY: 448AN XY: 723622
GnomAD4 exome
AF:
AC:
1059
AN:
1455662
Hom.:
Cov.:
31
AF XY:
AC XY:
448
AN XY:
723622
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00756 AC: 1152AN: 152328Hom.: 11 Cov.: 32 AF XY: 0.00714 AC XY: 532AN XY: 74494
GnomAD4 genome
AF:
AC:
1152
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
532
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 09, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at